Oracle Corp Japan
TSE:4716
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
10 825
15 785
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Oracle Corp Japan
Current Assets | 40B |
Cash & Short-Term Investments | 20B |
Receivables | 16.7B |
Other Current Assets | 3.3B |
Non-Current Assets | 222.2B |
PP&E | 34.9B |
Other Non-Current Assets | 187.3B |
Current Liabilities | 141.4B |
Accounts Payable | 11.4B |
Accrued Liabilities | 1B |
Other Current Liabilities | 129B |
Non-Current Liabilities | 1m |
Other Non-Current Liabilities | 1m |
Balance Sheet
Oracle Corp Japan
May-2015 | May-2016 | May-2017 | May-2018 | May-2019 | May-2020 | May-2021 | May-2022 | May-2023 | May-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
127 194
|
59 644
|
43 025
|
169 326
|
65 505
|
60 091
|
53 964
|
60 142
|
104 531
|
91 904
|
|
Cash Equivalents |
127 194
|
59 644
|
43 025
|
169 326
|
65 505
|
60 091
|
53 964
|
60 142
|
104 531
|
91 904
|
|
Total Receivables |
17 576
|
119 672
|
109 927
|
19 859
|
20 271
|
186 526
|
18 779
|
20 764
|
21 330
|
21 182
|
|
Accounts Receivables |
17 576
|
19 672
|
19 627
|
19 859
|
20 271
|
26 526
|
18 779
|
20 764
|
21 330
|
21 182
|
|
Other Receivables |
0
|
100 000
|
90 300
|
0
|
0
|
160 000
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
3 738
|
4 203
|
4 669
|
3 105
|
7 229
|
3 215
|
8 295
|
3 894
|
4 970
|
5 743
|
|
Total Current Assets |
148 508
|
183 519
|
157 621
|
192 290
|
93 005
|
249 832
|
81 038
|
84 800
|
130 831
|
118 829
|
|
PP&E Net |
39 631
|
39 085
|
40 089
|
39 863
|
40 889
|
38 895
|
36 894
|
35 796
|
34 973
|
34 236
|
|
PP&E Gross |
39 631
|
39 085
|
40 089
|
39 863
|
40 889
|
38 895
|
36 894
|
35 796
|
34 973
|
34 236
|
|
Accumulated Depreciation |
8 490
|
8 711
|
9 917
|
11 441
|
13 039
|
14 647
|
16 237
|
17 307
|
16 385
|
16 581
|
|
Intangible Assets |
7
|
5
|
6
|
4
|
2
|
1
|
0
|
1
|
1
|
0
|
|
Note Receivable |
0
|
0
|
0
|
34
|
130 034
|
0
|
210 000
|
110 000
|
110 000
|
182 000
|
|
Long-Term Investments |
36
|
36
|
36
|
36
|
36
|
36
|
36
|
36
|
36
|
36
|
|
Other Long-Term Assets |
665
|
757
|
979
|
4 282
|
5 552
|
5 375
|
6 031
|
6 235
|
5 174
|
5 058
|
|
Total Assets |
188 847
N/A
|
223 402
+18%
|
198 731
-11%
|
236 509
+19%
|
269 518
+14%
|
294 139
+9%
|
333 999
+14%
|
236 868
-29%
|
281 015
+19%
|
340 159
+21%
|
|
Liabilities | |||||||||||
Accounts Payable |
10 008
|
10 514
|
12 028
|
13 087
|
15 910
|
10 501
|
9 379
|
8 918
|
10 193
|
12 618
|
|
Accrued Liabilities |
1 774
|
2 033
|
2 057
|
2 288
|
2 592
|
2 347
|
2 132
|
1 974
|
1 924
|
1 781
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
63 230
|
74 619
|
78 855
|
89 700
|
90 720
|
89 920
|
102 488
|
100 620
|
113 044
|
133 964
|
|
Total Current Liabilities |
75 012
|
87 166
|
92 940
|
105 075
|
109 222
|
102 768
|
113 999
|
111 512
|
125 161
|
148 363
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
9
|
9
|
8
|
9
|
8
|
9
|
1
|
1
|
0
|
1
|
|
Total Liabilities |
75 021
N/A
|
87 175
+16%
|
92 948
+7%
|
105 084
+13%
|
109 230
+4%
|
102 777
-6%
|
114 000
+11%
|
111 513
-2%
|
125 161
+12%
|
148 364
+19%
|
|
Equity | |||||||||||
Common Stock |
22 743
|
23 209
|
23 755
|
24 480
|
24 679
|
24 884
|
25 033
|
25 067
|
25 111
|
25 175
|
|
Retained Earnings |
85 283
|
106 677
|
75 819
|
99 712
|
128 789
|
159 002
|
189 042
|
93 267
|
124 731
|
159 531
|
|
Additional Paid In Capital |
6 094
|
6 560
|
7 106
|
7 831
|
8 030
|
8 235
|
8 384
|
8 418
|
8 462
|
8 526
|
|
Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Treasury Stock |
295
|
0
|
898
|
599
|
1 211
|
759
|
2 461
|
1 399
|
2 452
|
1 438
|
|
Other Equity |
1
|
2
|
1
|
1
|
1
|
0
|
1
|
2
|
2
|
1
|
|
Total Equity |
113 826
N/A
|
136 227
+20%
|
105 783
-22%
|
131 425
+24%
|
160 288
+22%
|
191 362
+19%
|
219 999
+15%
|
125 355
-43%
|
155 854
+24%
|
191 795
+23%
|
|
Total Liabilities & Equity |
188 847
N/A
|
223 402
+18%
|
198 731
-11%
|
236 509
+19%
|
269 518
+14%
|
294 139
+9%
|
333 999
+14%
|
236 868
-29%
|
281 015
+19%
|
340 159
+21%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
127
|
127
|
128
|
128
|
128
|
128
|
128
|
128
|
128
|
128
|